A Phase 1b, Open-Label, Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Adult Patients with Presumed Nonalcoholic Steatohepatitis (NASH)
Clinical Trial Grant
Administered By
Radiology, Abdominal Imaging
Awarded By
Corcept Therapeutics, Inc.
Start Date
October 1, 2021
End Date
October 21, 2024
Administered By
Radiology, Abdominal Imaging
Awarded By
Corcept Therapeutics, Inc.
Start Date
October 1, 2021
End Date
October 21, 2024